|
ZNF543 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.510400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.470390E-01 |
| Normal-vs-Stage2 |
3.539000E-01 |
| Normal-vs-Stage3 |
1.237070E-03 |
| Normal-vs-Stage4 |
8.07860000000549E-05 |
| Stage1-vs-Stage2 |
6.088300E-02 |
| Stage1-vs-Stage3 |
4.69539999992108E-07 |
| Stage1-vs-Stage4 |
2.68790000257368E-08 |
| Stage2-vs-Stage3 |
1.049820E-01 |
| Stage2-vs-Stage4 |
1.913750E-02 |
| Stage3-vs-Stage4 |
3.370200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.483000E-01 |
| Normal-vs-AfricanAmerican |
2.052600E-01 |
| Normal-vs-Asian |
2.368400E-01 |
| Caucasian-vs-AfricanAmerican |
5.133200E-01 |
| Caucasian-vs-Asian |
2.920200E-02 |
| AfricanAmerican-vs-Asian |
3.326400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.122300E-02 |
| Normal-vs-Female |
9.630000E-01 |
| Male-vs-Female |
6.513700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.559800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.603600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.319800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.267630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.782200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.503200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.551800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.903700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.176820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.523600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.980800E-03 |
| Normal-vs-Grade 2 |
2.594000E-01 |
| Normal-vs-Grade 3 |
1.538180E-02 |
| Normal-vs-Grade 4 |
3.89379999998773E-06 |
| Grade 1-vs-Grade 2 |
4.157700E-03 |
| Grade 1-vs-Grade 3 |
1.93969999995325E-06 |
| Grade 1-vs-Grade 4 |
9.9457000413139E-09 |
| Grade 2-vs-Grade 3 |
1.040040E-04 |
| Grade 2-vs-Grade 4 |
8.80149997328772E-09 |
| Grade 3-vs-Grade 4 |
6.717500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.348100E-02 |
| Normal-vs-ccB subtype |
1.217930E-02 |
| ccA subtype-vs-ccB subtype |
3.90600000010899E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.472600E-01 |
| Normal-vs-N1 |
3.420800E-04 |
| N0-vs-N1 |
1.710040E-02 |
|
|
